| SECURITIES AND EXCHANGE COMMISSION |
| Pursuant to Section 13 or 15(d) of |
| the Securities and Exchange Act 1934 |
Date of Report (Date of earliest event reported): | October 14, 2009 |
IntegraMed America, Inc, |
(Exact name of registrant as specified in charter) |
|
Delaware |
(State of other jurisdiction of incorporation) |
0-20260 | 6-1150326 |
(Commission file Numbers) | (IRS Employer Identification No.) |
| |
Two Manhattanville Road, Purchase, NY | 10577 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone no. including area code: (914) 253-8000
|
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
□ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
□ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
□ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b) |
□ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 7.01 Regulation FD Disclosure
On October 14, 2009, Registrant issued a press release, which is attached hereto as exhibit 99.1 and incorporated herein by reference.
ITEM 9.01 | Financial Statements, Pro Forma Financial Information and Exhibits |
| Exhibit No. | Description of Exhibit |
| 99.1 | Registrant’s Press Release dated October 14, 2009. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | |
| | | IntegraMed America, Inc. (Registrant) |
| | | |
Date: October 14, 2009
| | By: | /s/John W. Hlywak, Jr. |
| | | John W. Hlywak, Jr. Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |
